Class 1C Antiarrhythmic Drugs in
Atrial Fibrillation and Coronary Artery Disease
Peter G. Pantlin MD 1 , Robert M. Bober MD 1,2 , Michael L. Bernard MD PhD 1 , Sammy Khatib MD 1 , Glenn M. Polin MD 1 , Paul A. Rogers MD PhD 1 , and Daniel P. Morin MD MPH 1,2
1 – University of Queensland - Ochsner Clinical School, New Orleans, LA
2 – Ochsner Medical Center, New Orleans, LA
Made with FlippingBook Digital Publishing Software